Recurrent Rectal Cancer After Local Excision clinical trials

Explore recruiting recurrent rectal cancer after local excision clinical trials.

Recruiting recurrent rectal cancer after local excision studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Recurrent Rectal Cancer After Local Excision trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as pre-operative treatment for locally recurrent rectal cancer (GRECCAR – PRODIGE – FRENCH) - GRECCAR 15

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Recurrent Rectal Cancer After Local Excision trials by city

Recurrent Rectal Cancer After Local Excision in Toronto Recurrent Rectal Cancer After Local Excision in Vancouver Recurrent Rectal Cancer After Local Excision in Montreal Recurrent Rectal Cancer After Local Excision in Calgary Recurrent Rectal Cancer After Local Excision in Edmonton Recurrent Rectal Cancer After Local Excision in Ottawa Recurrent Rectal Cancer After Local Excision in Winnipeg Recurrent Rectal Cancer After Local Excision in Quebec City Recurrent Rectal Cancer After Local Excision in Hamilton Recurrent Rectal Cancer After Local Excision in Kitchener Recurrent Rectal Cancer After Local Excision in London Recurrent Rectal Cancer After Local Excision in Halifax Recurrent Rectal Cancer After Local Excision in New York Recurrent Rectal Cancer After Local Excision in Los Angeles Recurrent Rectal Cancer After Local Excision in Chicago Recurrent Rectal Cancer After Local Excision in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease